Napa 2019 • Request an Invite →
VP of Research & Policy, Ewing Marion Kauffman Foundation
Chairman, CEO, & Founder, Alexandria Real Estate Equities
Partner, Third Rock Ventures
Partner at New Enterprise Associates
Co-Founder and CEO, DNAnexus
Senior health advisor for Esri
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
Managing Partner at Pappas Ventures
May 21, 2019 · Boston
May 29, 2019 · San Diego
June 13, 2019 · San Francisco
Exelixis (NASDAQ: EXEL) is a South San Francisco biotechnology company developing drugs for thyroid cancer, prostate cancer, and other conditions.
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
Sponsored · Whitepaper
Keep easily accessible, historical records to aid in root cause analysis for deviations
Implementing electronic solutions for risk mitigation
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.